Logo Logo Logo Logo
PL
  • Home
  • About Us
    • Our Partners
    • Work with us
  • Offer
    • HTA Reports
      • Scoping
      • Clinical analysis
      • Economic analysis
      • Budget Impact Analysis
      • Rationalisation analysis
    • Strategic consulting
    • Training courses
    • IT tools
    • Studies and registers
    • DTP
  • Database
    • Glossary
    • Bibliography
    • Publications
    • Posters
  • Contact
  • GO TO IKAR PRO
  • Home
  • About Us
    • Our Partners
    • Work with us
  • Offer
    • HTA Reports
      • Scoping
      • Clinical analysis
      • Economic analysis
      • Budget Impact Analysis
      • Rationalisation analysis
    • Strategic consulting
    • Training courses
    • IT tools
    • Studies and registers
    • DTP
  • Database
    • Glossary
    • Bibliography
    • Publications
    • Posters
  • Contact
  • GO TO IKAR PRO
HTA Consulting / 2018 / June

Archives

  • August 2021
  • July 2021
  • May 2021
  • April 2021
  • March 2021
  • January 2021
  • October 2020
  • September 2020
  • April 2020
  • February 2019
  • January 2019
  • December 2018
  • November 2018
  • October 2018
  • September 2018
  • August 2018
  • July 2018
  • June 2018
  • May 2018
  • April 2018
  • March 2018
  • November 2017
  • October 2017
  • May 2017
  • March 2017
  • October 2016
  • August 2016
  • June 2016
  • May 2016

Recent Posts

  • Medical Fund in Poland – report
  • Medical Fund in Poland – IDA report
  • Medical Fund in Poland – report
  • TOP10 reimbursement value in Poland
  • Happy Easter!

Tags

75+ AOTMiT article Articles ceestahc clinical conferences database ebhc economic EU Events Fundusz Medyczny holidays IDA ikarpro ispor Medical Fund nfz poster presentation publication refundation reimbursement report Rzeczpospolita symposium team
June 28, 2018 In news

Vaccine VaxigripTetra® placed on the reimbursement list

Quadrivalent influenza vaccine (split virion), inactivated - VaxigripTetra® has been placed on the list of reimbursed drugs (Project can be seen here) (beside for the Protective Vaccination Program in Poland, where it has so far been recommended as a non-refundable national level http: // szczepienia.pzh.gov.pl/kalendarzi-szczepien/,

Share
  • Facebook
  • Twitter
  • Google+
  • LinkedIn
June 26, 2018 In news

PZ: Familial hypercholesterolemia does not hurt, it kills young people

Polityka Zdrowotna lately published the article Familial hypercholesterolemia does not hurt, it kills young people (Hipercholesterolemia rodzinna nie boli, zabija młodych), in which Magdalena Władysiuk, Vice President of HTA Consulting, speaks about the costs related to heart attacks, stroke and peripheral vascular diseases.The full text of

Share
  • Facebook
  • Twitter
  • Google+
  • LinkedIn
June 22, 2018 In news

NTM 2018 – Where we are, where we are heading?

On June 25, 2018 in Warsaw the National Conference of the Association of People with Urinary Incontinence (NTM) "UroConti" will be held, entitled: "NTM 2018 - WHERE WE ARE, WHERE WE ARE HEADING?".HTA Consulting will also take part in the event - Piotr Miazga will present

Share
  • Facebook
  • Twitter
  • Google+
  • LinkedIn
June 19, 2018 In news

Infliximab – official price, limit, real price

4 of brands of infliximab (Remicade, Inflectra, Remisima and Flixabi) are reimbursement in Poland under 6 drug programs. Since the start of the reimbursement in 2012, the funding limit for 1 mg of infliximab has decreased by about 33%, while the volume-weighted average real price

Share
  • Facebook
  • Twitter
  • Google+
  • LinkedIn
Copyright by HTA Consulting 2016
Prosimy o zapoznanie się z poniższymi informacjami oraz wyrażenie zgody przez kliknięcie pola „Akceptuję”. Zgodę można wycofać w dowolnym czasie. Ta strona wykorzystuje pliki cookies. Informacje zawarte w cookies wykorzystujemy m.in. w celach statystycznych i funkcjonalnych. Dalsze korzystanie z serwisu oznacza, że zgadzają się Państwo na ich zapisanie w pamięci Państwa urządzenia. Mogą Państwo samodzielnie zarządzać plikami cookies zmieniając odpowiednio ustawienia w swojej przeglądarce. W związku z powyższym zgadzam się na przetwarzanie w celach analitycznych, statystycznych i marketingowych moich danych osobowych zbieranych w ramach korzystania przeze mnie ze strony internetowej hta.pl, w tym zapisywanych w plikach cookies przez administratora danych również po rozpoczęciu obowiązywania RODO (czyli po 25 maja 2018 roku). Wyrażenie zgody jest dobrowolne. Mają Państwo prawo do jej wycofania. Wycofanie zgody nie będzie miało wpływu na zgodność z prawem przetwarzania na podstawie zgody przed jej wycofaniem.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Akceptuj Czytaj więcej
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT